ZA978087B - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
ZA978087B
ZA978087B ZA978087A ZA978087A ZA978087B ZA 978087 B ZA978087 B ZA 978087B ZA 978087 A ZA978087 A ZA 978087A ZA 978087 A ZA978087 A ZA 978087A ZA 978087 B ZA978087 B ZA 978087B
Authority
ZA
South Africa
Prior art keywords
pharmaceuticals
Prior art date
Application number
ZA978087A
Other languages
English (en)
Inventor
Michael Fedouloff
David William Guest
Gillian Elizabeth Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA978087B publication Critical patent/ZA978087B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Optical Couplings Of Light Guides (AREA)
ZA978087A 1996-09-11 1997-09-09 Pharmaceuticals ZA978087B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9618967.5A GB9618967D0 (en) 1996-09-11 1996-09-11 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA978087B true ZA978087B (en) 1999-03-09

Family

ID=10799764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA978087A ZA978087B (en) 1996-09-11 1997-09-09 Pharmaceuticals

Country Status (30)

Country Link
US (1) US6331631B1 (fr)
EP (1) EP0927163B1 (fr)
JP (2) JP3748570B2 (fr)
KR (1) KR100525703B1 (fr)
CN (1) CN1102927C (fr)
AR (1) AR008174A1 (fr)
AT (1) ATE358121T1 (fr)
AU (1) AU725210B2 (fr)
BR (1) BR9712014A (fr)
CA (1) CA2266468C (fr)
CO (1) CO4930263A1 (fr)
CY (1) CY2590B2 (fr)
CZ (1) CZ290932B6 (fr)
DE (1) DE69737529T2 (fr)
DK (1) DK0927163T3 (fr)
ES (1) ES2285732T3 (fr)
GB (1) GB9618967D0 (fr)
HK (1) HK1020963A1 (fr)
HU (1) HUP9904155A3 (fr)
IL (1) IL128785A0 (fr)
NO (1) NO312587B1 (fr)
NZ (1) NZ334272A (fr)
PL (1) PL191373B1 (fr)
PT (1) PT927163E (fr)
SA (1) SA97180387B1 (fr)
SI (1) SI0927163T1 (fr)
TR (1) TR199900493T2 (fr)
TW (1) TW432048B (fr)
WO (1) WO1998011067A1 (fr)
ZA (1) ZA978087B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals
US20020091271A1 (en) 1998-07-16 2002-07-11 Smithkline Beecham Plc Process for the preparation of an indole derivative
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
CN104557672B (zh) * 2015-01-26 2016-09-21 湖南华腾制药有限公司 一种1位取代哌啶衍生物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821904B2 (ja) * 1975-04-04 1983-05-04 住友化学工業株式会社 シンキナメタノ−アントラセンユウドウタイノセイゾウホウホウ
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
AT394715B (de) * 1990-08-14 1992-06-10 Chemie Linz Gmbh Verfahren zur n-alkylierung von harnstoffen
DE69229674T2 (de) * 1991-09-12 2000-04-06 Smithkline Beecham P.L.C. 5-ht4 rezeptor antagonisten
MA22647A1 (fr) * 1991-09-14 1993-04-01 Smithkline Beecham Plc Procede de preparation d'un ester ou d'un amide d'un nouveau produit .
ES2219813T3 (es) * 1992-03-12 2004-12-01 Smithkline Beecham Plc N-(1-nbutil-4-piperidinil)metil-3,4-dihidro-2h-1,3-oxazino-3,2-a-indol-10-carboxamida, o una de sus sales farmaceuticamente aceptables.
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
JPH08502283A (ja) * 1992-10-16 1996-03-12 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5−ht▲下4▼レセプターアンタゴニスト用の縮合環系n−アルキルピペリジニル−4−メチルカルボン酸エステル/アミド
DE4427836A1 (de) * 1994-08-05 1996-02-08 Hoechst Ag Verbindungen aus der Reihe der Phosphane, Verfahren zu ihrer Herstellung sowie ihre Verwendung
CA2222532A1 (fr) 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Derives de l'indazole a groupe amino monocyclique
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
CN1102927C (zh) 2003-03-12
HUP9904155A3 (en) 2001-01-29
NZ334272A (en) 2000-08-25
DE69737529T2 (de) 2008-01-31
ATE358121T1 (de) 2007-04-15
SI0927163T1 (sl) 2007-08-31
AU4776497A (en) 1998-04-02
SA97180387B1 (ar) 2006-11-04
ES2285732T3 (es) 2007-11-16
DE69737529D1 (de) 2007-05-10
HUP9904155A2 (hu) 2000-05-28
PL332088A1 (en) 1999-08-30
GB9618967D0 (en) 1996-10-23
NO312587B1 (no) 2002-06-03
DK0927163T3 (da) 2007-08-06
CN1230179A (zh) 1999-09-29
CZ290932B6 (cs) 2002-11-13
EP0927163B1 (fr) 2007-03-28
JP2005220126A (ja) 2005-08-18
PT927163E (pt) 2007-07-06
CA2266468C (fr) 2005-10-25
CZ80999A3 (cs) 1999-11-17
JP3748570B2 (ja) 2006-02-22
US6331631B1 (en) 2001-12-18
KR100525703B1 (ko) 2005-11-03
TW432048B (en) 2001-05-01
CA2266468A1 (fr) 1998-03-19
AU725210B2 (en) 2000-10-05
AR008174A1 (es) 1999-12-09
TR199900493T2 (xx) 1999-06-21
CY2590B2 (en) 2009-11-04
IL128785A0 (en) 2000-01-31
JP2001500148A (ja) 2001-01-09
NO991148D0 (no) 1999-03-10
EP0927163A1 (fr) 1999-07-07
PL191373B1 (pl) 2006-05-31
NO991148L (no) 1999-03-10
BR9712014A (pt) 1999-08-24
CO4930263A1 (es) 2000-06-27
HK1020963A1 (en) 2000-05-26
WO1998011067A1 (fr) 1998-03-19
KR20000038041A (ko) 2000-07-05

Similar Documents

Publication Publication Date Title
GB9615202D0 (en) Pharmaceuticals
GB9601544D0 (en) Pharmaceuticals
EG23684A (en) Pharmaceuticals
GB9618967D0 (en) Pharmaceuticals
ZA972684B (en) Pharmaceuticals
GB9606414D0 (en) Pharmaceuticals
GB9621183D0 (en) Pharmaceuticals
GB9606744D0 (en) Pharmaceuticals
GB9606766D0 (en) Pharmaceuticals
GB9605568D0 (en) Pharmaceuticals
GB9604909D0 (en) Pharmaceuticals
GB9604671D0 (en) Pharmaceuticals
GB9604453D0 (en) Pharmaceuticals
GB9604447D0 (en) Pharmaceuticals
GB9602403D0 (en) Pharmaceuticals
GB9602133D0 (en) Pharmaceuticals
GB9602132D0 (en) Pharmaceuticals
GB9615273D0 (en) Pharmaceuticals
GB9607132D0 (en) Pharmaceuticals
GB9615275D0 (en) Pharmaceuticals
GB9610906D0 (en) Pharmaceuticals
ZA9710729B (en) Pharmaceuticals
GR970100281A (en) Pharmaceuticals
GB9624784D0 (en) Pharmaceuticals
GB9621184D0 (en) Pharmaceuticals